Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ABLYNX-65533/news/ABLYNX-OPENS-RECRUITMENT-FOR-FIRST-IN-INFANT-PHASE-IIa-STUDY-WITH-ITS-ANTI-RSV-NANOBODY-ALX-0171-19553177/?utm_source=whatsapp&utm_medium=social&utm_campaign=share